In various human tumor types such as acute and chronic leukemia [268], different malignant lymphomas [265, 266, 269], colorectal carcinoma [270], breast cancer [271] and gastric carcinoma [272], the tumor suppressor activity of Id4 is abrogated through epigenetic inactivation of its promoter by methylation during cancer development. This evidence concerns the gene ID4 and neoplasm.